|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| License and other revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net: | |||||
| Interest income | |||||
| Accretion of debt discount (Note 5) | |||||
| Change in fair value of derivative (Note 5) | |||||
| Sublease income | |||||
| Impairment loss on right-of-use assets | |||||
| Total other income, net | |||||
| Net loss before income taxes | |||||
| Income tax provision | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted average common shares outstanding used in computing net loss per share, basic | |||||
| Weighted average common shares outstanding used in computing net loss per share, diluted |
Loading...
